In hepatocellular carcinoma, inhibition of checkpoint kinase 1 (CHK1) increases IRF1 expression to induce apoptosis and trigger antitumor immunity through major histocompatibility complex (MHC) class I-associated chain A (MICA) [48]. The gene discussed is IRF1; the disease is hepatocellular carcinoma.